4. In addition to the 7 conditions listed above, the Writing Group noted that ventilator efficiency is a primary marker in assessing severity, prognosis, and post-surgical improvements in patients with valvular disease/dysfunction such as severe aortic stenosis and mitral valve disease or dysfunction.
5. The Writing Group developed a CPX algorithm for apparently healthy individuals because there is sufficient evidence and opportunities for apparently healthy individuals to access CPX services. While the group does not currently recommend CPX testing for apparently healthy individuals as a standard of care, nor are the services currently reimbursable, the data from this testing are valuable towards predicting risk of future adverse events and should be considered when available.
6. While it is not a required measurement, the Writing Group revised the Universal Reporting Sheet to include a section comparing and reporting the relationship between the exercise tidal volume loop and maximal flow volume loop. This addition is used to identify a possible expiratory flow limitation, which could help to explain the mechanism for exercise intolerance and abnormal symptomatology.
7. Two CPX variables consistently provide prognostic value: peak oxygen consumption (VO2) and the minute ventilation -carbon dioxide production (VE-VCO2) relationship (i.e., ventilatory efficiency). VO2 at ventilatory threshold (VT) was not included in the 2012 algorithms for prognostic assessment, however the data now support its inclusion as a signification prognostic marker for pre-surgical CPX assessments.
8. The 2012 CPX reporting sheet included assessments of VO2 at VT and this focused update describes how this information can be used to identify appropriate targets for aerobic exercise training in apparently healthy and medically-stable individuals (e.g., heart rate and workload). 
